Dr. Michelle Melisko Discusses Access to Care for Breast Cancer Patients
Автор: AJMCtv MJH
Загружено: 2012-01-30
Просмотров: 942
Описание:
Dr. Michelle E. Melisko, Assistant Clinical Professor, UCSF, Helen Diller Family Comprehensive Cancer Center, explains how drug shortages are affecting patients with breast cancer and the potential impact to cost and outcomes.
Dr. Melisko discusses the Paclitaxel shortages that have impacted the ability to start patients with clinical trials. Physiscians are being asked to prescribe alternative drugs and only use Paclitaxel when absolutely necessary. A recommended alternate to Taxol is another Albumin-bound Paclitaxel, however it is costly. Doxil has been a more serious shortage since the middle of August. Patients were able to switch to Adriamycin which has more toxicity and side affects. However, Dr. Melisko does not feel it will necessarily impact the long term prognosis since there are other drugs to be given. It is stressful for the patients and physicians to not be able to rely on using a specific drug.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
